Gossamer Bio, Inc.
Pharmaceutical Preparations · SAN DIEGO · CA
Moderate confidence (50%)
Updated Oct 13, 2026, 12:05 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Gossamer Bio, Inc. received a delisting notice from its exchange (Apr 8, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Gossamer Bio, Inc. received a delisting notice from its exchange
Apr 8, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 8, 2026, Gossamer Bio, Inc. (the Company ) received a written notice from the staff (the Staff ) of the Listing Qualifications Department of the Nasdaq Stock Market ( Nasdaq ), notifying the Company that, for the 30 consecutive business day period between February 24, 2026 through April 7, 2026, the Company s common stock, $0.0001 par value per share (the Common Stock ), had not maintained a minimum bid price of $1.00 per share, required for continued listing on the Nasdaq Gl…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker GOSS on Nasdaq.
- SEC CIK
- 0001728117
- Website
- —
- —
- Headquarters
- SAN DIEGO, CA
- Also known as
- —
- Legal entities
- Gossamer Bio, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Gossamer Bio, Inc. — Pharmaceutical Preparations (SIC 2834) — SAN DIEGO, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 8, 2026, Gossamer Bio, Inc. (the Company ) received a written notice from the staff (the Staff ) of the Listing Qualifications Department of the Nasdaq Stock Market ( Nasdaq ), notifying the Company that, for the 30 consecutive business day period between February 24, 2026 through April 7, 2026, the Company s common stock, $0.0001 par value per share (the Common Stock ), had not maintained a minimum bid price of $1.00 per share, required for continued listing on the Nasdaq Gl…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:31 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:04 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.